Phreesia, Inc. (NYSE:PHR) Receives $33.85 Consensus PT from Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have received a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, twelve have issued a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $33.8462.

Several equities research analysts recently issued reports on PHR shares. Truist Financial raised their target price on shares of Phreesia from $35.00 to $36.00 and gave the company a “buy” rating in a research note on Friday, September 5th. Mizuho started coverage on shares of Phreesia in a research note on Wednesday, August 27th. They issued an “outperform” rating and a $36.00 target price for the company. Stephens restated an “overweight” rating and set a $32.00 price objective on shares of Phreesia in a research report on Wednesday, September 3rd. JMP Securities raised their price objective on shares of Phreesia from $30.00 to $34.00 and gave the stock a “market outperform” rating in a research report on Monday, September 8th. Finally, Needham & Company LLC raised their price objective on shares of Phreesia from $29.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday, September 5th.

Insider Activity

In other Phreesia news, CFO Balaji Gandhi sold 4,183 shares of the firm’s stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total transaction of $97,380.24. Following the completion of the sale, the chief financial officer directly owned 99,125 shares in the company, valued at $2,307,630. This trade represents a 4.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Amy Beth Vanduyn sold 1,762 shares of the firm’s stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $23.28, for a total transaction of $41,019.36. Following the sale, the senior vice president owned 112,479 shares of the company’s stock, valued at $2,618,511.12. This trade represents a 1.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 85,532 shares of company stock valued at $2,530,640. Company insiders own 5.50% of the company’s stock.

Institutional Investors Weigh In On Phreesia

Hedge funds and other institutional investors have recently made changes to their positions in the business. KBC Group NV acquired a new stake in shares of Phreesia in the first quarter valued at approximately $74,000. Farther Finance Advisors LLC raised its position in shares of Phreesia by 9,375.0% in the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after buying an additional 3,000 shares in the last quarter. CWM LLC raised its position in shares of Phreesia by 994.9% in the first quarter. CWM LLC now owns 4,040 shares of the company’s stock valued at $103,000 after buying an additional 3,671 shares in the last quarter. Smartleaf Asset Management LLC raised its position in shares of Phreesia by 53.0% in the first quarter. Smartleaf Asset Management LLC now owns 5,267 shares of the company’s stock valued at $137,000 after buying an additional 1,825 shares in the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Phreesia by 10,605.7% in the first quarter. GAMMA Investing LLC now owns 5,674 shares of the company’s stock valued at $145,000 after buying an additional 5,621 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Trading Up 2.8%

Shares of NYSE:PHR opened at $22.92 on Friday. Phreesia has a 52-week low of $17.07 and a 52-week high of $32.76. The company has a market capitalization of $1.37 billion, a P/E ratio of -54.56 and a beta of 0.68. The company has a 50-day simple moving average of $26.02 and a 200 day simple moving average of $25.99. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.12 and a current ratio of 2.12.

Phreesia (NYSE:PHR) last issued its earnings results on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.08. Phreesia had a negative net margin of 5.35% and a negative return on equity of 8.75%. The business had revenue of $117.26 million during the quarter, compared to the consensus estimate of $116.39 million. During the same period last year, the business posted ($0.03) EPS. Phreesia’s revenue was up 14.9% on a year-over-year basis. Phreesia has set its FY 2026 guidance at EPS. Sell-side analysts forecast that Phreesia will post -1.1 earnings per share for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.